EuroScience.Net

This week in European sciences -- week 45
 

Overview
Spiegel online interviews former British Minister for the environment, Michael Meacher, on his view about the recent published GMO studies in UK. Die Zeit is pesimistic about chancellor Schröder's year of innovation scheduled for 2003. The Guardian tours British labs to search the nanobots. Corriere della Sera about a new gadget to change traffic lights from red to green via remote-control. FAZ writes about discarding hormone-replacement therapy in women's menopause. Corriere della Sera on biometeorological forecasts. Süddeutsche Zeitung reports about German doctors examining the outspread of AIDS in Africa. Dagens Nyheter wonders if hibernating animals may give clues for medical therapies, also five questions and answers about solar storms. Svenska Dagbladet on bird migration and the question how they find their way forth and back. In addition: WSJ and NY Times on genetics influencing osteoporosis development.
 

>> former issues
 
 
 

The GM Crop Story: Deep Mistrust in Scientists

Michael Sontheimer interviews in Spiegel online (November 7, 2003) former British minister for the environment, Michael Meacher, about the recent UK studies of GM crops. Meacher initiated in 1999 the studies on sugar beet, maize and oilseed rape which came to a result in last october. He speaks as an emotional opponent of GMO: The giant GM corporate players Monsanto and Bayer are the bad guys on the scene. Even the relatively positive outcome of the maize study is criticized as being manipulated by Bayer. Meacher sees a deep mistrust of people in scientists. After looking at the environment he asks for detailled studies on the health risks of GM food.
 

 

Spiegel online
November 7, 2003

What will Germany's Year of Innovation Bring?

The economy in Germany is suffering, the tax income decreases - German people are in a bad mood. "It´s time to react," the German chancellor, Gerhard Schröder, might have had in mind when he announced the year 2004 to be the year of innovation. In the German weekly Die Zeit (November 7, 2003) Gero von Randow discusses the reasons behind and the perspectives of the plans. He does not sound very optimistic: No more money for research, and hence no innovation - in contrast to Schröder's intention.
In addition, Dirk Assendorpf writes about the crisis of the german railway-system. 13 percent of trains in Germany are late. Computer simulation predicted the chaos already one year ago.
 

 

Die Zeit
November 7, 2003

Should We be Scared Of Nanotech?

How seriously should we take the hype about nanotechnology, asks Ian Sample in his report in The Guardian (November 6, 2003). He toured some British labs and came back with interesting insights. First, although for most of us nanotech means building very tiny machines, it turned out for the author that those "do not exist - and won't for a very long time to come." Second, there is lots of money being set aside for nanotechnology. Why not take it? Hence, "attaching nano to a research project can make all the difference" if you are looking for funding, writes Sample. Finally, Sample concluded that "we should probably be more concerned about inhaling nanoparticles" than about dangerous nanobots. For instance, nanoparticles are used in sun creams and car paint. But what happens exactly when they hit the human body or the environment? That is still an open question - and should be addressed by research and legislation.
 

 

The Guardian
November 6, 2003

Green lights forever

In a humourous piece, Alessandra Farkas writes in the Corriere (November 5, 2003) that a new traffic gadget is becoming increasingly common in the U.S.: the traffic light remote-control. Originally devised for use by the emergency services, the dashboard-mounted box is now available even on eBay and allows its owner to change any suitably equipped traffic light from red to green by means of an infra-red signal. Needless to say that the authorities aren't very happy about this!
 

 

Corriere della Sera
November 5, 2003

Hormone Therapy to be Phased Out

Recent studies show that the established hormone-replacement therapy against symptoms in women's menopause can also endanger the patient's health through higher risks for breast cancer and strokes. The German federal drug commission (Bundesinstitut für Arzneimittel und Medizinprodukte) therefore decided to outlaw the treatment. But it's not clear yet how to find a replacement for the therapy, writes Hildegard Kaulen in FAZ (November 5, 2003). Already about four to five million women are treated with estrogenes and gestagenes, both are given during hormone replacement. The drug commission of a German medical body rewrote its guidelines for hormone replacement (www.akdae.de). According to this paper hormone therapy should only be applied in case of strong climacterical symptoms and after an appropriate risk assessment. Also, the dosages used should be as low as possible. The commission stressed that women's menopause is no disease per se, but a natural part of life. Anyway, in recent years, the medical body admitted, doctors got used prescribing medication routinely.
 

 

Frankfurter Allgemeine Zeitung
November 5, 2003

Headache forecast

The Corriere della Sera (November 4, 2003) reports on a new kind of weather forecast provided by the Italian National Research Council (CNR). The Florence-based Centre for Biometeorology has developed a computer programme that calculates correlations between past weather conditions and clinical reports in order to predict weather-related health hazards in the future. Following the example of similar services in the U.S., the centre will shortly launch a website featuring interactive maps that contain biometeorological forecasts, making it possible for those at risk to take precautions in time before the temperature drops or the humidity rises.
 

 

Corriere della Sera
November 4, 2003

AIDS Along the Trans-African-Highway

Researchers of Munich University, Germany, study the outspread of AIDS in the Tanzanian town Mbeya where the Trans-African-Highway passes by. Christina Berndt visited them and reports about their work in Süddeutsche Zeitung (November 4, 2003). The place is important on the roadmap of Africa because at Mbeya the highway devides into roads for Sambia and South Africa. People passing by visit the prostitutes in the many bars of the place. The result: All subtypes of H.I.V., the virus causing AIDS, are present. The researchers examine the health status of the prostitutes, register whether they are H.I.V. positive or not, cure side-infections and give medical advice such as using condoms. Because of this, they are largely accepted in the local community, which makes it easier to convince local doctors to participate in the project. Most of the latter still discard AIDS as a diagnosis. There is no money for medical treatment of AIDS, but the researchers hope to get funded by the EU project EDCTP which spends 600 million euros to fight poverty-related diseases like AIDS, malaria and tuberculosis.
 

 

Süddeutsche Zeitung
November 4, 2003

Variant of Gene Increases Risk of Osteoporosis

Dr. Kari Stefansson of Iceland discovered a gene that, "in certain versions, triples a person's risk of developing osteoporosis and related bone fractures," Sharon Begley reports in The Wall Street Journal (November 3, 2003). Stefanssons article also received attention on The New York Times' front page. Nicholas Wade writes that the risk to develop osteoporosis is three times as high in people with three specific variants of the gene BMP2 (bone morphogenetic protein 2). "We think BMP2 influences the peak bone mass" reached in young adulthood, Stefansson is being quoted in The Wall Street Journal. Steffanson is the founder of Decode Genetics, a company that specializes in the discovery of genes that can cause common diseases. Roche Diagnostics is currently busy developing a test to discover these variant forms of the gene. The test can be expected to be available early next year, Stefansson says. People only need to be tested once and when diagnosed as being among the high-risk population for osteoporosis, they can be prescribed a high-calcium diet and a lot of exercise.
 

 

New York Times
Wall Street Journal
November 3, 2003

Researchers look for a medical benefit in studying hibernation

It's inevitably getting ever darker and colder in Sweden. In an appropriate piece for the approaching winter, Per Snaprud reports in Dagens Nyheter (November 2, 2003) on research in hibernation and its potential medical implications. For instance, during hibernation the core temperature of brown bears drops to approximately 33 degrees Celsius, heart rate drops by 75 percent and energy consumption by more than 50 percent. Organs of hibernating mammals show an amazing resistance against oxygen deprivation. Human tissues, however, are very sensitive to a lack of oxygen. Especially organs stored for transplantation react critically to oxygen deficit. A human liver only survives for one day at freezer temperature. Hannah Carey from Wisconsin University uses ground squirrels as model organisms in her attempts to develop media, which may prolong the lifetime of donated organs. The research has so far not resulted in any immediate pay-off for transplantation medicine, but Carey and other scientists seem confident that hibernating mammals offer one exceptionally promising avenue for research.
Karin Bojs addresses five questions about the recent solar storm to Henrik Lundstedt, astrophysicist from Lund University. Lundstedt is especially concerned about ways to predict such occurrences in the future. He refers to project "Lois" which consists of 15,000 small aerials in the forests of Småland. This set-up should, according to Lundstedt, enable researchers much better than today to determine the direction and speed of solar winds.
 

 
Dagens Nyheter
November 2, 2003

Open Questions in Bird Migration

Most avian migrants should have left northern Europe by now. A quite large proportion of these migrants will show up again next spring. Malin Eborn recounts in Svenska Dagbladet (November 2, 2003) how scientists from Lund University's bird migration research group try to figure out how birds manage to perform two such demanding trips every year. One puzzling question is: how do the birds find their way? The birds' magnetic compass sense poses many profound problems, because it remains fundamentally unclear how sensory mechanisms function. Recent research by Rachel Muheim, a PhD student at Lund, demonstrates that the magnetic sense of birds interacts with light: birds can only use the directional information of the magnetic field if light of certain wavelengths is available. A current theory states that retinal molecules become sensitive to the magnetic field if they are in an excited state. Birds, however, also have magnetite crystals in their brains, which may function like the magnetic needle in a compass. According to Thomas Alerstam, leader of the research group, it is possible that migrants use the magnetite to determine their absolute position and then employ "magnetic vision" to set a course.
 

 
Svenska Dagbladet
November 2, 2003

Feedback

We are glad to receive your comments! Send us an e-mail